2.0803
price down icon5.87%   -0.1297
after-market Handel nachbörslich: 2.12 0.0397 +1.91%
loading
Schlusskurs vom Vortag:
$2.21
Offen:
$2.132
24-Stunden-Volumen:
23,867
Relative Volume:
0.11
Marktkapitalisierung:
$6.56M
Einnahmen:
$960.60K
Nettoeinkommen (Verlust:
$-7.10M
KGV:
-0.2752
EPS:
-7.56
Netto-Cashflow:
$-8.00M
1W Leistung:
-8.36%
1M Leistung:
-5.44%
6M Leistung:
-47.33%
1J Leistung:
-73.20%
1-Tages-Spanne:
Value
$2.05
$2.1345
1-Wochen-Bereich:
Value
$2.05
$2.275
52-Wochen-Spanne:
Value
$1.8301
$14.92

Soligenix Inc Stock (SNGX) Company Profile

Name
Firmenname
Soligenix Inc
Name
Telefon
609-538-8200
Name
Adresse
29 EMMONS DRIVE, PRINCETON
Name
Mitarbeiter
0
Name
Twitter
@Soligenix_Inc
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
SNGX's Discussions on Twitter

Vergleichen Sie SNGX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SNGX
Soligenix Inc
2.0803 6.56M 960.60K -7.10M -8.00M -7.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 66.76B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Soligenix Inc Stock (SNGX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-07-28 Herabstufung Dawson James Buy → Neutral
2018-01-31 Herabstufung H.C. Wainwright Buy → Neutral
2017-08-14 Bestätigt Maxim Group Buy
2017-07-17 Eingeleitet H.C. Wainwright Buy

Soligenix Inc Aktie (SNGX) Neueste Nachrichten

pulisher
Mar 29, 2025

Zacks Small Cap Decreases Earnings Estimates for Soligenix - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Zacks Maintains $35.00 Price Per Share Valuation for Soligenix (NASDAQ: SNGX) Amid Promising Vaccine and CTCL Therapy Progress - Barchart.com

Mar 28, 2025
pulisher
Mar 28, 2025

Q1 Earnings Forecast for Soligenix Issued By Zacks Small Cap - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

SNGX: Preclinical Data Shows CiVax™ Booster Induces Broad Protection Against COVID-19… - Yahoo Finance

Mar 26, 2025
pulisher
Mar 25, 2025

CiVax booster shows broad COVID-19 variant protection By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

IBN Initiates Coverage of Soligenix Inc. - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

First National Financial Corporation to Host First Quarter Earnings Call on April 30, 2025 - The Globe and Mail

Mar 25, 2025
pulisher
Mar 25, 2025

CiVax booster shows broad COVID-19 variant protection - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants - PR Newswire

Mar 25, 2025
pulisher
Mar 21, 2025

Soligenix Inc. (SNGX) reports earnings - Quartz

Mar 21, 2025
pulisher
Mar 21, 2025

SOLIGENIX, INC. SEC 10-K Report - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Trumps Year-End Financials - Baystreet.ca

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix reports progress and 2024 financials By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix reports progress and 2024 financials - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results - Quantisnow

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Financial Results Reveal Widening Losses While Clinical Pipeline Expands - StockTitan

Mar 21, 2025
pulisher
Mar 19, 2025

Why Soligenix (NASDAQ: SNGX) Is ‘One to Watch’ - The Globe and Mail

Mar 19, 2025
pulisher
Mar 14, 2025

Soligenix Inc expected to post a loss of 95 cents a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Soligenix (SNGX) Projected to Post Earnings on Friday - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Soligenix (NASDAQ: SNGX) Is ‘One to Watch’ - The Globe and Mail

Mar 13, 2025
pulisher
Mar 13, 2025

Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’ - Financial Content

Mar 13, 2025
pulisher
Mar 11, 2025

Soligenix (SNGX) Projected to Post Earnings on Thursday - Armenian Reporter

Mar 11, 2025
pulisher
Mar 09, 2025

AllPennyStocks.com News: A Steady Stream of News and Developments Pushes Soligenix Near 52 Week High - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 08, 2025

Soligenix, Inc. (NASDAQ:SNGX) Sees Large Decrease in Short Interest - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

Soligenix (SNGX) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

BiomednewsbreaksSoligenix Inc. (SNGX) To Present Hybrytetm And SGX302 Data At Dermatology Conferences - MENAFN.COM

Mar 06, 2025
pulisher
Feb 28, 2025

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 26, 2025

Soligenix Aims To Push The Boundaries In Treating Rare Diseases - The Globe and Mail

Feb 26, 2025
pulisher
Feb 25, 2025

Soligenix Advances Innovative Treatments for Rare Diseases - citybuzz -

Feb 25, 2025
pulisher
Feb 24, 2025

TALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight - GlobeNewswire Inc.

Feb 24, 2025
pulisher
Feb 21, 2025

Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026 - The Globe and Mail

Feb 21, 2025
pulisher
Feb 21, 2025

Silicon Valley - Financial Content

Feb 21, 2025
pulisher
Feb 20, 2025

SoundHound AI Stock at a Crossroads—Is a Bottom in Sight? - The Globe and Mail

Feb 20, 2025
pulisher
Feb 12, 2025

Soligenix settles debt with Pontifax lenders - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Soligenix, Inc. Repays and Terminates Loan Agreement with Pontifax Medison FinanceOn February 5, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced in an SEC Filing the full repayment and termination of all outstanding obligations under the Loan and Se - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

Soligenix Repays Loan, Boosting Financial Flexibility - TipRanks

Feb 10, 2025
pulisher
Feb 04, 2025

Soligenix on Way to Bio Conference in NYC - Baystreet.ca

Feb 04, 2025
pulisher
Feb 04, 2025

Rare Disease Pioneer Soligenix Takes Center Stage at Major Biotech Investor Summit - StockTitan

Feb 04, 2025
pulisher
Jan 30, 2025

Symbol Lookup - GuruFocus.com

Jan 30, 2025
pulisher
Jan 29, 2025

SPI Energy and Soligenix Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV - ACCESS Newswire

Jan 29, 2025
pulisher
Jan 26, 2025

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 25, 2025

Soligenix (NASDAQ:SNGX) & Rhythm Pharmaceuticals (NASDAQ:RYTM) Head to Head Contrast - Defense World

Jan 25, 2025
pulisher
Jan 23, 2025

Soligenix (SNGX) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Soligenix (NASDAQ: $SNGX) Unveils Two-Pronged Approach To Tackle Rare Diseases & Unmet Medical Needs - MSN

Jan 22, 2025

Finanzdaten der Soligenix Inc-Aktie (SNGX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):